Biotechnology News

August 17, 2012

BOSTON--(BUSINESS WIRE)--The Biogen Idec Foundation and Teach For America today announced a new collaboration in support of Science, Technology, Engineering, and Math (STEM) education. A $100,000 grant from The Biogen Idec Foundation will be...

August 17, 2012

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: Probi: (STO:PROB) Both the intensity and the frequency of the key symptoms of Irritable Bowel Syndrome (IBS) declined significantly following ingestion of Probi’s bacteria Lactobacillus plantarum...

August 17, 2012

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: Biotage AB: (STO:BIOTA) Interim report for the period January – June 2012 Second quarter April – June 2012 · Group net sales in the second quarter 2012 increased by 24 percent to 122.3 MSEK (98.6...

August 16, 2012

BROOMFIELD, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), today announced that Richard B. Brewer, 61, Chairman of its Board of Directors, has died after a long battle with multiple myeloma, a type of blood cancer. “Dick will be...

August 16, 2012

GETINGE, Sweden--(BUSINESS WIRE)--Getinge has today signed a definitive agreement with US-based Kinetic Concepts Inc. (KCI) to acquire KCI’s Therapeutic Support Systems (TSS) business. Getinge is currently a major player in pressure ulcer...

August 16, 2012

BIRMINGHAM, Ala.--(BUSINESS WIRE)--IMS®, a leader in surgical device and instrument management, has been named sole distributor for RxEnergy’s NeverDie™ Lithium Ion Batteries.

August 16, 2012

WASHINGTON--(BUSINESS WIRE)--BIO announces that registration is now available for the 11th Annual BIO Investor Forum, an international biotech investor conference, to take place October 9-10, 2012 in San Francisco, California.

August 16, 2012

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc. (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the quarter...

August 16, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, through 2021 the uptake of three new market entrants, Roche/Genentech’s Perjeta (...

August 16, 2012

EXTON, Pa.--(BUSINESS WIRE)--IRIS International (NASDAQ:IRIS) to power its world-class remote equipment monitoring and support solution with ThingWorx.

August 16, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm (NASDAQ:FLDM) today announced the pricing of an underwritten public offering of 3,660,000 shares of its common stock at a price to the public of $14.25 per share.

August 16, 2012

ANNAPOLIS, Md.--(BUSINESS WIRE)--Zephyr Technology, a global leader in physiological status monitoring, has developed a system for monitoring patients wirelessly that will improve health care and reduce costs.

August 16, 2012

NEWTOWN, Pa.--(BUSINESS WIRE)--Quotient Biodiagnostics, Inc., dedicated to providing high quality immunohematology products to blood banks and hospitals, today announced that it has entered into a 36 month supply agreement with Premier healthcare...

August 16, 2012

BILLERICA, Mass.--(BUSINESS WIRE)--Pharmalucence has received FDA approval for use of Sulfur Colloid Injection in the localization of lymph nodes in malignant melanoma patients. FDA grants this indication Orphan Drug status.

August 16, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and BioTime’s subsidiary OncoCyte Corporation today announced the publication of a scientific report on the gene COL10A1 and its potential as a marker for numerous types of human...

August 16, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--DARA BioSciences, Inc. (Nasdaq:DARA) announced that it has entered into an exclusive distribution agreement with Seyer Pharmatec Inc. for the sale and distribution of Soltamox® (tamoxifen citrate).

August 16, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--The majority of pharma companies in the North America, Europe and the Asia-Pacific region use patient reported outcomes (PROs) to supplement outcomes data, according to new study.

August 16, 2012

NEW YORK--(BUSINESS WIRE)--Seth Lederman, M.D., President and CEO of New York City-based Tonix Pharmaceuticals Holding Corp. (“TONIX” or the “Company”) (OTCBB:TNXP) says that a good night’s sleep is a potentially powerful, but currently elusive,...

August 16, 2012

BRUSSELS--(BUSINESS WIRE)--This October, EuropaBio’s European Forum for Industrial Biotechnology and the Biobased Economy (EFIB) brings together a panel of multinational CEOs to discuss the evolution of a world leading EU bioeconomy. The...

August 16, 2012

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: Probi (STO:PROB): Second quarter 2012 · Net sales amounted to MSEK 21.9 (24.0). · Operating profit totalled MSEK 2.2 (6.3). · Profit after tax amounted to MSEK 2.0 (4.9). · Profit after tax per...

August 16, 2012

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Diffusion Pharmaceuticals LLC, a biotechnology company focused on innovative cancer treatments, today announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350,...

August 15, 2012

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization urges consideration of the impact on advanced biofuel producers that will occur from a waiver of the Renewable Fuel Standard

August 15, 2012

INDIANAPOLIS & ADELAIDE, Australia--(BUSINESS WIRE)--Dow AgroSciences and the Australian Centre for Plant Functional Genomics have entered into a crop improvement research, option, and license agreement.

August 15, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has priced its previously announced offering of senior notes: $500 million aggregate principal amount of 1....

August 15, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm (NASDAQ: FLDM) today announced that it intends to offer shares of its common stock in an underwritten public offering.

August 15, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals today announced the results of voting at its 2012 Annual Meeting of Stockholders (the Annual Meeting) held August 14, 2012.

August 15, 2012

TALLAHASSEE, Fla.--(BUSINESS WIRE)--Konky Sotomayor, DVM, developer of the Salmogenics Vaccine, was appointed Chief Scientist of Global Green, Inc.

August 15, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--A newly published benchmarking study found that pharmaceutical companies spend upwards of $30 million on their global medical science liaison (MSL) operations.

August 15, 2012

IRVINE, Calif.--(BUSINESS WIRE)--Cortex Pharmaceuticals, Inc. (OTCBB:CORX) reported a net loss of approximately $995,000, or $0.01 per share, for the quarter ended June 30, 2012, compared with a net loss of approximately $356,000, or $0.00 per...

August 15, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it intends to offer senior notes to fund its acquisition of One Lambda and for other general corporate purposes...

August 15, 2012

MT. OLIVE, N.J.--(BUSINESS WIRE)--Specialty pharmacy takes center stage when leading experts in the pharmaceutical and biotech manufacturers' industries gather in Las Vegas, September 19-21 to discuss the current changes and trends developing in...

August 15, 2012

JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, today reported its results for the quarter ended June 30, 2012. Kinneret Savitsky, Ph.D., CEO of BioLineRx, remarked, “During the...

August 15, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Relypsa Inc announced an $80M Series C preferred stock financing to fund late-stage development, submission of an NDA and commercial planning for patiromer (RLY5016), a high capacity potassium binder.

August 15, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--Verdezyne, Inc., a privately-held industrial biotechnology company focused on producing renewable chemicals from non-petroleum sources, has been granted a United States Patent for a bio-based adipic acid...

August 15, 2012

SAN FRANCISCO--(BUSINESS WIRE)--The Thiel Foundation announced today three new grants awarded through Breakout Labs. The newest awards focus on solutions at the intersection of biology and advanced technologies.

August 15, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka America Pharmaceutical, Inc. today announced the launch of patient management programs for Sprycel® (dasatinib) patients with a select group of specialty...

August 15, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences announced today that it has initiated a Phase 1/2a clinical study with its lead candidate, GEN-003. GEN-003 is an investigational vaccine designed to stimulate T cell and B cell immune...

August 15, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (OTC: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and...

August 15, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (NYSE MKT: IMUC) (“ImmunoCellular” or the “Company”), today announced second quarter results for the period ended June 30, 2012. Highlights of the second quarter and recent weeks...

August 15, 2012

SAN DIEGO--(BUSINESS WIRE)--Epic Sciences, Inc. (“Epic”), a privately held cancer diagnostics company, announced today that it has established collaborations with six pharmaceutical partners employing Epic’s proprietary Circulating Tumor Cell (“...

August 15, 2012

BANGKOK--(BUSINESS WIRE)--Vejthani Hospital offers Sprained Ankle Treatment, the way to relieve your pain at Vejthani Orthopaedic Clinic in Bangkok Thailand.

August 14, 2012

HACKENSACK, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (ADMA), a late-stage biotechnology company focused on the development and commercialization of human plasma and plasma-derived therapeutics, today reported financial results for its second...

August 14, 2012

MINNEAPOLIS--(BUSINESS WIRE)--HEI, Inc. (Pink Sheets: HEII; http://www.heii.com) today announced its financial results for the second quarter of fiscal year 2012, which ended June 30,...

August 14, 2012

WESTBURY, N.Y.--(BUSINESS WIRE)--Vasomedical, Inc. today reported its operating results for the three and six months ended June 30, 2012. Vasomedical Announces 48.7% Increase in Revenue for the Second Quarter 2012.

August 14, 2012

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology released its financial results for the second quarter of 2012 and provided an update on the development program for its lead drug candidate, neratinib.

August 14, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics Reports Second Quarter 2012 Financial Results

August 14, 2012

TEWKSBURY, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, today reported results for the three and six months ended June 30, 2012. Full financial statements and...

August 14, 2012

ALACHUA, Fla.--(BUSINESS WIRE)--AxoGen Reports Record 2Q12 revenues